
Dennis H. Pedder
Examiner (ID: 14040, Phone: (571)272-6667 , Office: P/3612 )
| Most Active Art Unit | 3612 |
| Art Unit(s) | 2899, 3102, 3106, 3612, 3642 |
| Total Applications | 5987 |
| Issued Applications | 4919 |
| Pending Applications | 211 |
| Abandoned Applications | 929 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10438522
[patent_doc_number] => 20150323535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-11-12
[patent_title] => 'METHOD FOR DIAGNOSING NEURODEGENERATIVE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 14/716201
[patent_app_country] => US
[patent_app_date] => 2015-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7909
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14716201
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/716201 | Method for diagnosing neurodegenerative diseases | May 18, 2015 | Issued |
Array
(
[id] => 10365853
[patent_doc_number] => 20150250859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-10
[patent_title] => 'METHODS FOR TREATING NEUROLOGICAL CONDITIONS AND COMPOSITIONS AND MATERIALS THEREFOR'
[patent_app_type] => utility
[patent_app_number] => 14/714626
[patent_app_country] => US
[patent_app_date] => 2015-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12850
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14714626
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/714626 | Methods for treating neurological conditions and compositions and materials therefor | May 17, 2015 | Issued |
Array
(
[id] => 10353551
[patent_doc_number] => 20150238556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-27
[patent_title] => 'NEURITOGENIC PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/710896
[patent_app_country] => US
[patent_app_date] => 2015-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 16584
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14710896
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/710896 | NEURITOGENIC PEPTIDES | May 12, 2015 | Abandoned |
Array
(
[id] => 10701654
[patent_doc_number] => 20160047801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-18
[patent_title] => 'METHOD AND SYSTEM TO DETECT, DIAGNOSE, AND MONITOR THE PROGRESSION OF ALZHEIMER\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/706835
[patent_app_country] => US
[patent_app_date] => 2015-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 11316
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14706835
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/706835 | METHOD AND SYSTEM TO DETECT, DIAGNOSE, AND MONITOR THE PROGRESSION OF ALZHEIMER'S DISEASE | May 6, 2015 | Abandoned |
Array
(
[id] => 10422542
[patent_doc_number] => 20150307553
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-29
[patent_title] => 'SYNTHETIC ANALOGUES OF NEURAL REGENERATION PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/701991
[patent_app_country] => US
[patent_app_date] => 2015-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11163
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14701991
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/701991 | Synthetic analogues of neural regeneration peptides | Apr 30, 2015 | Issued |
Array
(
[id] => 10380620
[patent_doc_number] => 20150265628
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-24
[patent_title] => 'GENOMIC TESTING FOR EFFECTIVE THERAPIES AND DETERMINATION OF DOSING STRATEGY'
[patent_app_type] => utility
[patent_app_number] => 14/664433
[patent_app_country] => US
[patent_app_date] => 2015-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 17537
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14664433
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/664433 | GENOMIC TESTING FOR EFFECTIVE THERAPIES AND DETERMINATION OF DOSING STRATEGY | Mar 19, 2015 | Abandoned |
Array
(
[id] => 10373187
[patent_doc_number] => 20150258193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-17
[patent_title] => 'DIAGNOSTIC MARKER FOR TREATMENT OF CEREBRAL ISCHEMIA'
[patent_app_type] => utility
[patent_app_number] => 14/657777
[patent_app_country] => US
[patent_app_date] => 2015-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5212
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14657777
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/657777 | Diagnostic marker for treatment of cerebral ischemia | Mar 12, 2015 | Issued |
Array
(
[id] => 10422589
[patent_doc_number] => 20150307601
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-29
[patent_title] => 'ANTIBODIES SPECIFIC FOR SOLUBLE AMYLOID BETA PEPTIDE PROTOFIBRILS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/627161
[patent_app_country] => US
[patent_app_date] => 2015-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7610
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14627161
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/627161 | ANTIBODIES SPECIFIC FOR SOLUBLE AMYLOID BETA PEPTIDE PROTOFIBRILS AND USES THEREOF | Feb 19, 2015 | |
Array
(
[id] => 11929769
[patent_doc_number] => 09796755
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-24
[patent_title] => 'Methods of treating depression and other related diseases'
[patent_app_type] => utility
[patent_app_number] => 14/616220
[patent_app_country] => US
[patent_app_date] => 2015-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 10724
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14616220
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/616220 | Methods of treating depression and other related diseases | Feb 5, 2015 | Issued |
Array
(
[id] => 11549670
[patent_doc_number] => 09618511
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-04-11
[patent_title] => 'Methods and compositions for treating alzheimer\'s disease'
[patent_app_type] => utility
[patent_app_number] => 14/609845
[patent_app_country] => US
[patent_app_date] => 2015-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 36
[patent_no_of_words] => 28905
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14609845
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/609845 | Methods and compositions for treating alzheimer's disease | Jan 29, 2015 | Issued |
Array
(
[id] => 10365844
[patent_doc_number] => 20150250849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-10
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING PRURITUS'
[patent_app_type] => utility
[patent_app_number] => 14/579545
[patent_app_country] => US
[patent_app_date] => 2014-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 77
[patent_figures_cnt] => 77
[patent_no_of_words] => 22069
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14579545
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/579545 | Compositions and methods for treating pruritus | Dec 21, 2014 | Issued |
Array
(
[id] => 13170455
[patent_doc_number] => 10101338
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-16
[patent_title] => Biomarkers
[patent_app_type] => utility
[patent_app_number] => 14/570076
[patent_app_country] => US
[patent_app_date] => 2014-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15191
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14570076
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/570076 | Biomarkers | Dec 14, 2014 | Issued |
Array
(
[id] => 10275245
[patent_doc_number] => 20150160241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-11
[patent_title] => 'GAMMA-AMINOBUTYRIC ACID A RECEPTOR SUBUNIT BIOMARKERS'
[patent_app_type] => utility
[patent_app_number] => 14/563725
[patent_app_country] => US
[patent_app_date] => 2014-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12515
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14563725
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/563725 | GAMMA-AMINOBUTYRIC ACID A RECEPTOR SUBUNIT BIOMARKERS | Dec 7, 2014 | Abandoned |
Array
(
[id] => 10305084
[patent_doc_number] => 20150190083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-09
[patent_title] => 'Biomarkers For Treatment Outcomes'
[patent_app_type] => utility
[patent_app_number] => 14/557132
[patent_app_country] => US
[patent_app_date] => 2014-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 18762
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14557132
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/557132 | Biomarkers For Treatment Outcomes | Nov 30, 2014 | Abandoned |
Array
(
[id] => 10311618
[patent_doc_number] => 20150196621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-07-16
[patent_title] => 'COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF NEUROINJURY AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/540728
[patent_app_country] => US
[patent_app_date] => 2014-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8615
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14540728
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/540728 | COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF NEUROINJURY AND METHODS OF USE THEREOF | Nov 12, 2014 | Abandoned |
Array
(
[id] => 9901521
[patent_doc_number] => 20150056721
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-02-26
[patent_title] => 'SNTF IS A BLOOD BIOMARKER FOR THE DIAGNOSIS AND PROGNOSIS OF SPORTS-RELATED CONCUSSION'
[patent_app_type] => utility
[patent_app_number] => 14/537642
[patent_app_country] => US
[patent_app_date] => 2014-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 18420
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14537642
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/537642 | SNTF is a blood biomarker for the diagnosis and prognosis of sports-related concussion | Nov 9, 2014 | Issued |
Array
(
[id] => 10234284
[patent_doc_number] => 20150119278
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-30
[patent_title] => 'BIOMARKERS AND DIAGNOSTIC METHODS FOR ALZHEIMER\'S DISEASE AND OTHER NEURODEGENERATIVE DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/522585
[patent_app_country] => US
[patent_app_date] => 2014-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17843
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14522585
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/522585 | Biomarkers and diagnostic methods for Alzheimer's disease and other neurodegenerative disorders | Oct 23, 2014 | Issued |
Array
(
[id] => 9838964
[patent_doc_number] => 20150031045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'MARKERS FOR DIAGNOSING AMYOTROPHIC LATERAL SCLEROSIS'
[patent_app_type] => utility
[patent_app_number] => 14/511757
[patent_app_country] => US
[patent_app_date] => 2014-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 33
[patent_no_of_words] => 29278
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14511757
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/511757 | MARKERS FOR DIAGNOSING AMYOTROPHIC LATERAL SCLEROSIS | Oct 9, 2014 | Abandoned |
Array
(
[id] => 9811942
[patent_doc_number] => 20150023888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-22
[patent_title] => 'Method of Using Dihydroergotamine for Pre-emptive Treatment of Migraine'
[patent_app_type] => utility
[patent_app_number] => 14/503027
[patent_app_country] => US
[patent_app_date] => 2014-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9997
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14503027
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/503027 | Method of Using Dihydroergotamine for Pre-emptive Treatment of Migraine | Sep 29, 2014 | Abandoned |
Array
(
[id] => 10226784
[patent_doc_number] => 20150111777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-23
[patent_title] => 'BIOMARKER FOR EARLY NEURODEGENERATION DETECTION'
[patent_app_type] => utility
[patent_app_number] => 14/495071
[patent_app_country] => US
[patent_app_date] => 2014-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9693
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14495071
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/495071 | BIOMARKER FOR EARLY NEURODEGENERATION DETECTION | Sep 23, 2014 | Abandoned |